Cargando…
Targeting natural products against SARS-CoV-2
The human coronavirus disease (COVID-19) pandemic is caused by a novel coronavirus; the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Natural products, secondary metabolites show positive leads with antiviral and immunotherapy treatments using genomic studies in silico docking. In addi...
Autores principales: | Al-Harrasi, Ahmed, Behl, Tapan, Upadhyay, Tanuj, Chigurupati, Sridevi, Bhatt, Shvetank, Sehgal, Aayush, Bhatia, Saurabh, Singh, Sukhbir, Sharma, Neelam, Vijayabalan, Shantini, Palanimuthu, Vasanth Raj, Das, Suprava, Kaur, Rajwinder, Aleya, Lotfi, Bungau, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972763/ https://www.ncbi.nlm.nih.gov/pubmed/35362883 http://dx.doi.org/10.1007/s11356-022-19770-2 |
Ejemplares similares
-
Targeting Probiotics in Rheumatoid Arthritis
por: Bungau, Simona Gabriela, et al.
Publicado: (2021) -
Exploring the role of cathepsin in rheumatoid arthritis
por: Behl, Tapan, et al.
Publicado: (2022) -
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
por: Behl, Tapan, et al.
Publicado: (2022) -
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
por: Behl, Tapan, et al.
Publicado: (2021) -
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
por: Sharma, Neelam, et al.
Publicado: (2022)